Literature DB >> 7405966

Effects of electronic fetal heart rate monitoring on perinatal outcome and obstetric practices.

E Mueller-Heubach, H M MacDonald, D Joret, M A Portman, D I Edelstone, S N Caritis.   

Abstract

Perinatal outcome and obstetric practices during 1970 and 1977 were compared. None of the 6,740 fetuses delivered with birth weights of 1,000 gm or greater in 1970 had electronic fetal monitoring (EFM). In 1977, 5,987 of 8,174 fetuses delivered had EFM (72.7%). High-risk factors were significantly more frequent in the pregnant patient population in 1977. The incidence of intrapartum stillbirths and severe birth asphyxia was significantly lower in 1977. These reductions remained significant when corrected for changes in obstetric practices other than EFM as well as for changes in patient population. The neonatal death rate was not significantly changed. The primary cesarean section rate increased from 4.4% to 10.1%, mostly because of a greater number of cesarean sections done for failure to progress in labor and breech presentation. Only 15% of the overall increase in cesarean section rate was because of a greater frequency of the indication of fetal distress. The incidence of severe birth asphyxia was the same among the unmonitored patients in 1970 and 1977. In 1977, however, the monitored patients had a significantly lower incidence of severe birth asphyxia than the unmonitored patients.

Entities:  

Mesh:

Year:  1980        PMID: 7405966     DOI: 10.1016/0002-9378(80)90881-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

Review 1.  Thirty years of electronic intrapartum fetal heart rate monitoring: discussion paper.

Authors:  H M Jenkins
Journal:  J R Soc Med       Date:  1989-04       Impact factor: 5.344

2.  Electronic fetal monitoring in relation to cesarean section delivery, for live births and stillbirths in the U.S., 1980.

Authors:  P J Placek; K G Keppel; S M Taffel; T L Liss
Journal:  Public Health Rep       Date:  1984 Mar-Apr       Impact factor: 2.792

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.